Glenn E. Petrie BA, PhD

Dr. Glenn Petrie has more than 25 years of experience in biopharmaceutical drug development. As a director at a major CRO he served as team leader in the development, Chemistry Manufacture and Control (CMC) design and IND submissions for a wide variety of biopharmaceuticals (monoclonal antibodies, drug conjugates, enzymes, peptides, etc.). He is a subject matter expert in the analysis of proteins including UPLC, LC/MS/MS, ELISAs and CE. As an SSA Dr. Petrie has been instrumental in the growth of EAG’s Biotech Group over the last 3 years creating a state-of-the- art laboratory. Dr. Petrie received his B.A. in Biochemistry from Rice University and his doctorate in Biochemistry from the University of Illinois Urbana-Champaign, as well as post-doctoral work at the Mayo Clinic.